Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.

NCT01251263 is registered in ClinicalTrials.gov with Scott and White Hospital & Clinic as lead sponsor.

NCT NCT01251263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01251263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
Lead sponsor
Scott and White Hospital & Clinic
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2010
Completion date
October 31, 2012
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual bleeding, menstrual migraines, menstrual spotting